Nanoplatform-Mediated Autophagy Regulation and Combined Anti-Tumor Therapy for Resistant Tumors

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. Ca A Cancer J Clinicians. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Dembic Z. Antitumor Drugs and Their Targets. Molecules. 2020;25(23):5776. doi:10.3390/molecules25235776
   PubMed Web of Science ®Google Scholar
• Sun J, Wei Q, Zhou Y, Wang J, Liu Q, Xu H. A systematic analysis of FDA-approved anticancer drugs. BMC Syst. Biol. 2017;11(Suppl 5):87. doi:10.1186/s12918-017-0464-7
   PubMedGoogle Scholar
• Sato R, Semba T, Saya H, Arima Y. Concise Review: stem Cells and Epithelial-Mesenchymal Transition in Cancer: biological Implications and Therapeutic Targets. Stem Cells (Dayton, Ohio). 2016;34(8):1997–2007. doi:10.1002/stem.2406
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sun M, Huang G, et al. Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy. Proc Natl Acad Sci USA. 2017;114(26):E5226–E5235. doi:10.1073/pnas.1705066114
   PubMed Web of Science ®Google Scholar
• Fairchild A, Tirumani SH, Rosenthal MH, et al. Hormonal therapy in oncology: a primer for the radiologist. AJR. 2015;204(6):W620–W630 . doi:10.2214/AJR.14.13604
   PubMed Web of Science ®Google Scholar
• Beck A, Wurch T, Bailly C, Corvaia N. Strategies and challenges for the next generation of therapeutic antibodies. Immunology. 2010;10(5):345–352.
   PubMed Web of Science ®Google Scholar
• Dobosz P, Dzieciątkowski T. The Intriguing History of Cancer Immunotherapy. Front Immunol. 2019;10:2965.
   PubMed Web of Science ®Google Scholar
• Duong MT, Qin Y, You SH, Min JJ. Bacteria-cancer interactions: bacteria-based cancer therapy. Exp. Mol. Med. 2019;51(12):1–15. doi:10.1038/s12276-019-0297-0
   PubMedGoogle Scholar
• Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. Cancer Cell. 2018;33(4):570–580. doi:10.1016/j.ccell.2018.03.015
   PubMed Web of Science ®Google Scholar
• Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Cancer. 2003;3(5):380–387. doi:10.1038/nrc1071
   PubMed Web of Science ®Google Scholar
• Nguyen PL, Gu X, Lipsitz SR, et al. Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol. 2011;29(12):1517–1524. doi:10.1200/JCO.2010.31.1217
   PubMed Web of Science ®Google Scholar
• Mignani S, Bryszewska M, Klajnert-Maculewicz B, Zablocka M, Majoral JP. Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report. Biomacromolecules. 2015;16(1):1–27. doi:10.1021/bm501285t
   PubMed Web of Science ®Google Scholar
• Hu CM, Zhang L. Nanoparticle- based combination therapy toward overcoming drug resistance in cancer. Biochem Pharmacol. 2012;83(8):1104–1111. doi:10.1016/j.bcp.2012.01.008
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Kang MH, Qasim M, Kim JH. Nanoparticle-Mediated Combination Therapy: two-in-One Approach for Cancer. Int J Mol Sci. 2018;19(10):3264. doi:10.3390/ijms19103264
   PubMed Web of Science ®Google Scholar
• Assaraf YG, Brozovic A, Gonçalves AC, et al. The multi-factorial nature of clinical multidrug resistance in cancer. Drug Resist Updat. 2019;46:100645. doi:10.1016/j.drup.2019.100645
   PubMed Web of Science ®Google Scholar
• Jin S, White E. Role of autophagy in cancer: management of metabolic stress. Autophagy. 2007;3(1):28–31. doi:10.4161/auto.3269
   PubMed Web of Science ®Google Scholar
• Dalby KN, Tekedereli I, Lopez-Berestein G, Ozpolat B. Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy. 2010;6(3):322–329. doi:10.4161/auto.6.3.11625
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sha R, Zhang L, et al. Harnessing copper-palladium alloy tetrapod nanoparticle-induced pro-survival autophagy for optimized photothermal therapy of drug-resistant cancer. Nat Commun. 2018;9(1):4236. doi:10.1038/s41467-018-06529-y
   PubMedGoogle Scholar
• Ge Y, Ma Y, Li L. The application of prodrug-based nano -drug delivery strategy in cancer combination therapy. Colloids Surf B Biointerfaces. 2016;146:482–489. doi:10.1016/j.colsurfb.2016.06.051
   PubMed Web of Science ®Google Scholar
• Olov N, Bagheri-Khoulenjani S, Mirzadeh H. Combinational drug delivery using nanocarriers for breast cancer treatments: a review. J Biomed Mater Res A. 2018;106(8):2272–2283. doi:10.1002/jbm.a.36410
   PubMed Web of Science ®Google Scholar
• Kankala RK, Liu CG, Chen AZ, et al. Overcoming Multidrug Resistance through the Synergistic Effects of Hierarchical pH-Sensitive, ROS-Generating Nanoreactors. ACS Biomater. Sci. Eng. 2017;3(10):2431–2442. doi:10.1021/acsbiomaterials.7b00569
   PubMed Web of Science ®Google Scholar
• Kankala K, Liu C-G, Yang D-Y, et al. Ultrasmall platinum nanoparticles enable deep tumor penetration and synergistic therapeutic abilities through free radical species-assisted catalysis to combat cancer multidrug resistance [J]. Chem Eng J. 2020;383:123138. doi:10.1016/j.cej.2019.123138
   Web of Science ®Google Scholar
• Duan C, Yu M, Xu J, Li BY, Zhao Y, Kankala RK. Overcoming Cancer Multi-drug Resistance (MDR): reasons, mechanisms, nanotherapeutic solutions, and challenges. Biomed Pharmacother. 2023;162:114643. doi:10.1016/j.biopha.2023.114643
   PubMed Web of Science ®Google Scholar
• Li T, Li J, Chen Z, et al. Glioma diagnosis and therapy: current challenges and nanomaterial-based solutions. J Controlled Release. 2022;352:338–370. doi:10.1016/j.jconrel.2022.09.065
   PubMed Web of Science ®Google Scholar
• Liu CG, Han YH, Kankala RK, Wang SB, Chen AZ. Subcellular Performance of Nanoparticles in Cancer Therapy. Int j Nanomed. 2020;15:675–704. doi:10.2147/IJN.S226186
   PubMed Web of Science ®Google Scholar
• Bayda S, Adeel M, Tuccinardi T, Cordani M, Rizzolio F. The History of Nanoscience and Nanotechnology: from Chemical-Physical Applications to Nanomedicine. Molecules. 2019;25(1):112. doi:10.3390/molecules25010112
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh M, Zhang W, Zou R, Sethi G, Klionsky DJ, Zhang X. A bioinformatics analysis, pre-clinical and clinical conception of autophagy in pancreatic cancer: complexity and simplicity in crosstalk. Pharmacol Res. 2023;194:106822. doi:10.1016/j.phrs.2023.106822
   PubMed Web of Science ®Google Scholar
• Pietrocola F, Bravo-San Pedro JM, Galluzzi L, Kroemer G. Autophagy in natural and therapy-driven anticancer immunosurveillance. Autophagy. 2017;13(12):2163–2170. doi:10.1080/15548627.2017.1310356
   PubMed Web of Science ®Google Scholar
• Wang C, Hu Q, Shen HM. Pharmacological inhibitors of autophagy as novel cancer therapeutic agents. Pharmacol Res. 2016;105:164–175. doi:10.1016/j.phrs.2016.01.028
   PubMed Web of Science ®Google Scholar
• Zhang SF, Wang XY, Fu ZQ, et al. TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer. Autophagy. 2015;11(2):225–238. doi:10.1080/15548627.2014.998931
   PubMed Web of Science ®Google Scholar
• Niu J, Yan T, Guo W, et al. The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma. Autophagy. 2023;19(6):1693–1710. doi:10.1080/15548627.2022.2150003
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wu J, Chen H, et al. KLF4 targets RAB26 and decreases 5-FU resistance through inhibiting autophagy in colon cancer. Cancer Biol Ther. 2023;24(1):2226353. doi:10.1080/15384047.2023.2226353
   PubMed Web of Science ®Google Scholar
• Chittaranjan S, Bortnik S, Dragowska WH, et al. Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer. Clin Cancer Res. 2014;20(12):3159–3173. doi:10.1158/1078-0432.CCR-13-2060
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Venida A, Yano J, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581(7806):100–105. doi:10.1038/s41586-020-2229-5
   PubMed Web of Science ®Google Scholar
• Lotsberg ML, Wnuk-Lipinska K, Terry S, et al. AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells. J Thorac Oncol. 2020;15(6):973–999. doi:10.1016/j.jtho.2020.01.015
   PubMed Web of Science ®Google Scholar
• Yu Z, Tang H, Chen S, et al. Exosomal LOC85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating ATG5-induced autophagy. Drug Resist Updat. 2023;67:100915. doi:10.1016/j.drup.2022.100915
   PubMed Web of Science ®Google Scholar
• Han M, Hu J, Lu P, et al. Exosome-transmitted reverses trastuzumab resistance by inhibiting ATG5 in breast cancer. Cell Death Dis. 2020;11(1):43. doi:10.1038/s41419-020-2250-5
   PubMed Web of Science ®Google Scholar
• Pai Bellare G, Saha B, Patro BS. Targeting autophagy reverses de novo resistance in homologous recombination repair proficient breast cancers to PARP inhibition. Br J Cancer. 2021;124(7):1260–1274. doi:10.1038/s41416-020-01238-0
   PubMed Web of Science ®Google Scholar
• Xu WP, Liu JP, Feng JF, et al. miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy. Gut. 2020;69(7):1309–1321. doi:10.1136/gutjnl-2019-318830
   PubMed Web of Science ®Google Scholar
• Zahedi S, Fitzwalter BE, Morin A, et al. Effect of early-stage autophagy inhibition in BRAFV600E autophagy -dependent brain tumor cells. Cell Death Dis. 2019;10(9):679. doi:10.1038/s41419-019-1880-y
   PubMedGoogle Scholar
• Bi J, Zhang Y, Malmrose PK, et al. Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer. Cell Death Dis. 2022;13(1):59. doi:10.1038/s41419-022-04508-2
   PubMed Web of Science ®Google Scholar
• Xu Q, Zhang H, Liu H, Han Y, Qiu W, Li Z. Inhibiting autophagy flux and DNA repair of tumor cells to boost radiotherapy of orthotopic glioblastoma. Biomaterials. 2022;280:121287. doi:10.1016/j.biomaterials.2021.121287
   PubMed Web of Science ®Google Scholar
• Liang B, Kong D, Liu Y, et al. Autophagy inhibition plays the synergetic killing roles with radiation in the multi-drug resistant SKVCR ovarian cancer cells. Radiat Oncol. 2012;7:213. doi:10.1186/1748-717X-7-213
   PubMed Web of Science ®Google Scholar
• Li Y, Cook KL, Yu W, et al. Inhibition of Antiestrogen-Promoted Pro-Survival Autophagy and Tamoxifen Resistance in Breast Cancer through Vitamin D Receptor. Nutrients. 2021;13(5):1715. doi:10.3390/nu13051715
   PubMed Web of Science ®Google Scholar
• Nguyen HG, Yang JC, Kung HJ, et al. Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model. Oncogene. 2014;33(36):4521–4530. doi:10.1038/onc.2014.25
   PubMed Web of Science ®Google Scholar
• Jiang L, Xu L, Xie J, et al. Inhibition of autophagy overcomes glucocorticoid resistance in lymphoid malignant cells. Cancer Biol Ther. 2015;16(3):466–476. doi:10.1080/15384047.2015.1016658
   PubMed Web of Science ®Google Scholar
• Wei MF, Chen MW, Chen KC, et al. Autophagy promotes resistance to photodynamic therapy-induced apoptosis selectively in colorectal cancer stem-like cells. Autophagy. 2014;10(7):1179–1192. doi:10.4161/auto.28679
   PubMed Web of Science ®Google Scholar
• Zanotto-Filho A, Braganhol E, Klafke K, et al. Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas. Cancer Lett. 2015;358(2):220–231. doi:10.1016/j.canlet.2014.12.044
   PubMed Web of Science ®Google Scholar
• Zeng T, Xu M, Zhang W, et al. Autophagy inhibition and microRNA‑199a‑5p upregulation in paclitaxel‑resistant A549/T lung cancer cells. Oncol Rep. 2021;46(1):149. doi:10.3892/or.2021.8100
   PubMed Web of Science ®Google Scholar
• Li H, Chen L, Li JJ, et al. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. J Hematol Oncol. 2018;11(1):70. doi:10.1186/s13045-018-0618-0
   PubMed Web of Science ®Google Scholar
• Xu W, Wei Q, Han M, et al. CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer. Int J Biol Sci. 2018;14(9):1054–1066. doi:10.7150/ijbs.25349
   PubMed Web of Science ®Google Scholar
• Zitkute V, Kukcinaviciute E, Jonusiene V, Starkuviene V, Sasnauskiene A. Differential effects of 5-fluorouracil and oxaliplatin on autophagy in chemoresistant colorectal cancer cells. J Cell Biochem. 2022;123(6):1103–1115. doi:10.1002/jcb.30267
   PubMed Web of Science ®Google Scholar
• Chen Y, Jia Y, Mao M, et al. PLAC8 promotes Adriamycin resistance via blocking autophagy in breast cancer. J Cell Mol Med. 2021;25(14):6948–6962. doi:10.1111/jcmm.16706
   PubMed Web of Science ®Google Scholar
• Li ZL, Zhang HL, Huang Y, et al. Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation. Nat Commun. 2020;11(1):3806. doi:10.1038/s41467-020-17395-y
   PubMed Web of Science ®Google Scholar
• Mele L, la Noce M, Paino F, et al. Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation. J Exp Clin Cancer Res. 2019;38(1):160. doi:10.1186/s13046-019-1164-5
   PubMedGoogle Scholar
• Wu FQ, Fang T, Yu LX, et al. ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α. J Hepatol. 2016;65(2):314–324. doi:10.1016/j.jhep.2016.04.019
   PubMed Web of Science ®Google Scholar
• Ning L, Guo-Chun Z, Sheng-Li A, et al. Inhibition of autophagy induced by PTEN loss promotes intrinsic breast cancer resistance to trastuzumab therapy. Tumour Biol. 2016;37(4):5445–5454. doi:10.1007/s13277-015-4392-0
   PubMedGoogle Scholar
• Yang Y, Li Y, Yang Q, et al. FAT4 activation inhibits epithelial-mesenchymal transition (EMT) by promoting autophagy in H2228/Cer cells. Med Oncol. 2022;40(1):64. doi:10.1007/s12032-022-01934-2
   PubMed Web of Science ®Google Scholar
• Thorburn J, Staskiewicz L, Goodall ML, et al. Non- cell-autonomous Effects of Autophagy Inhibition in Tumor Cells Promote Growth of Drug-resistant Cells. Mol Pharmacol. 2017;91(1):58–64. doi:10.1124/mol.116.106070
   PubMedGoogle Scholar
• He C, Dong X, Zhai B, et al. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway. Oncotarget. 2015;6(30):28867–28881. doi:10.18632/oncotarget.4814
   PubMedGoogle Scholar
• Zhai B, Hu F, Jiang X, et al. Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma. Mol Cancer Ther. 2014;13(6):1589–1598. doi:10.1158/1535-7163.MCT-13-1043
   PubMed Web of Science ®Google Scholar
• Xu J, Su Y, Xu A, et al. miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma. Mol Ther. 2019;27(3):559–570. doi:10.1016/j.ymthe.2019.01.012
   PubMed Web of Science ®Google Scholar
• Kaverina NV, Kadagidze ZG, Borovjagin AV, et al. Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX. Oncogene. 2018;37(46):6069–6082. doi:10.1038/s41388-018-0395-9
   PubMed Web of Science ®Google Scholar
• Qu YQ, Song LL, Xu SW, et al. Pomiferin targets SERCA, mTOR, and P-gp to induce autophagic cell death in apoptosis-resistant cancer cells, and reverses the MDR phenotype in cisplatin-resistant tumors in vivo. Pharmacol Res. 2023;191:106769. doi:10.1016/j.phrs.2023.106769
   PubMed Web of Science ®Google Scholar
• Yan J, Dou X, Zhou J, et al. Tubeimoside-I sensitizes colorectal cancer cells to chemotherapy by inducing ROS-mediated impaired autophagolysosomes accumulation. J Exp Clin Cancer Res. 2019;38(1):353. doi:10.1186/s13046-019-1355-0
   PubMed Web of Science ®Google Scholar
• Di Maio M, Chiodini P, Georgoulias V, et al. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer. J Clin Oncol. 2009;27(11):1836–1843. doi:10.1200/JCO.2008.17.5844
   PubMed Web of Science ®Google Scholar
• Zhang RX, Wong HL, Xue HY, Eoh JY, Wu XY. Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives. J Control Release. 2016;240:489–503. doi:10.1016/j.jconrel.2016.06.012
   PubMed Web of Science ®Google Scholar
• Landesman-Milo D, Ramishetti S, Peer D. Nanomedicine as an emerging platform for metastatic lung cancer therapy. Cancer Metastasis Rev. 2015;34(2):291–301. doi:10.1007/s10555-015-9554-4
   PubMed Web of Science ®Google Scholar
• Iyer AK, Singh A, Ganta S, Amiji MM. Role of integrated cancer nanomedicine in overcoming drug resistance. Adv. Drug Delivery Rev. 2013;65(13–14):1784–1802. doi:10.1016/j.addr.2013.07.012
   PubMed Web of Science ®Google Scholar
• Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl. 2014;53(46):12320–12364. doi:10.1002/anie.201403036
   PubMed Web of Science ®Google Scholar
• Banik BL, Fattahi P, Brown JL. Polymeric nanoparticles: the future of nanomedicine. Wiley interdisciplinary reviews. Nanomed Nanobiotechnol. 2016;8(2):271–299. doi:10.1002/wnan.1364
   Web of Science ®Google Scholar
• Brown PD, Patel PR. Nanomedicine: a pharma perspective. Wiley interdisciplinary reviews. Nanomed Nanobiotechnol. 2015;7(2):125–130. doi:10.1002/wnan.1288
   Web of Science ®Google Scholar
• Danhier F, Lecouturier N, Vroman B, et al. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Controlled Release. 2009;133(1):11–17. doi:10.1016/j.jconrel.2008.09.086
   PubMed Web of Science ®Google Scholar
• Jin C, Bai L, Wu H, Song W, Guo G, Dou K. Cytotoxicity of paclitaxel incorporated in PLGA nanoparticles on hypoxic human tumor cells. Pharm res. 2009;26(7):1776–1784. doi:10.1007/s11095-009-9889-z
   PubMed Web of Science ®Google Scholar
• Pérez-Herrero E, Fernández-Medarde A. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur j Pharm. 2015;93:52–79.
   Google Scholar
• Jadia R, Scandore C, Rai P. Nanoparticles for Effective Combination Therapy of Cancer. Int J Nanotechnol Nanomed. 2016;1(1):565.
   Google Scholar
• Zhang DY, Shen XZ, Wang JY, Dong L, Zheng YL, Wu LL. Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice. World J Gastroenterol. 2008;14(22):3554–3562. doi:10.3748/wjg.14.3554
   PubMed Web of Science ®Google Scholar
• Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev. 2012;41(7):2971–3010.
   PubMed Web of Science ®Google Scholar
• Lv S, Tang Z, Li M, et al. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer. Biomaterials. 2014;35(23):6118–6129. doi:10.1016/j.biomaterials.2014.04.034
   PubMed Web of Science ®Google Scholar
• Zucker D, Andriyanov AV, Steiner A, Raviv U, Barenholz Y. Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy. J Control Release. 2012;160(2):281–289.
   PubMed Web of Science ®Google Scholar
• Misra R, Sahoo SK. Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Mol Pharm. 2011;8(3):852–866. doi:10.1021/mp100455h
   PubMed Web of Science ®Google Scholar
• Sarisozen C, Abouzeid AH, Torchilin VP. The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors. Eur J Pharm Biopharm. 2014;88(2):539–550. doi:10.1016/j.ejpb.2014.07.001
   PubMed Web of Science ®Google Scholar
• Chiang CS, Hu SH, Liao BJ, Chang YC, Chen SY. Enhancement of cancer therapy efficacy by trastuzumab-conjugated and pH-sensitive nanocapsules with the simultaneous encapsulation of hydrophilic and hydrophobic compounds. Nanomedicine. 2014;10(1):99–107. doi:10.1016/j.nano.2013.07.009
   PubMed Web of Science ®Google Scholar
• Tang J, Zhang L, Gao H, et al. Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity. Drug Deliv. 2016;23(4):1130–1143. doi:10.3109/10717544.2014.990651
   PubMed Web of Science ®Google Scholar
• Zhang X, Zeng X, Liang X, et al. The chemotherapeutic potential of PEG-b-PLGA copolymer micelles that combine chloroquine as autophagy inhibitor and docetaxel as an anti-cancer drug. Biomaterials. 2014;35(33):9144–9154. doi:10.1016/j.biomaterials.2014.07.028
   PubMed Web of Science ®Google Scholar
• Song Q, Tan S, Zhuang X, et al. Nitric oxide releasing d-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin. Mol Pharm. 2014;11(11):4118–4129.
   PubMedGoogle Scholar
• Wan WJ, Qu CX, Zhou YJ, et al. Doxorubicin and siRNA-PD-L1 co-delivery with T7 modified ROS-sensitive nanoparticles for tumor chemoimmunotherapy. Int J Pharm. 2019;566:731–744. doi:10.1016/j.ijpharm.2019.06.030
   PubMed Web of Science ®Google Scholar
• Zhang F, Li M, Su Y, Zhou J, Wang W. A dual-targeting drug co-delivery system for tumor chemo- and gene combined therapy. Mater Sci Eng C Mater Biol Appl. 2016;64:208–218. doi:10.1016/j.msec.2016.03.083
   PubMed Web of Science ®Google Scholar
• Kang Y, Lu L, Lan J, et al. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA. Acta Biomater. 2018;68:137–153. doi:10.1016/j.actbio.2017.12.028
   PubMed Web of Science ®Google Scholar
• Ren Q, Liang Z, Jiang X, et al. Enzyme and pH dual-responsive hyaluronic acid nanoparticles mediated combination of photodynamic therapy and chemotherapy. Int J Biol Macromol. 2019;130:845–852.
   PubMed Web of Science ®Google Scholar
• Wang D, Xu Z, Yu H, et al. Treatment of metastatic breast cancer by combination of chemotherapy and photothermal ablation using doxorubicin-loaded DNA wrapped gold nanorods. Biomaterials. 2014;35(29):8374–8384. doi:10.1016/j.biomaterials.2014.05.094
   PubMed Web of Science ®Google Scholar
• Ren Y, Zhang H, Chen B, et al. Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance. Int J Nanomed. 2012;7:2261–2269. doi:10.2147/IJN.S29357
   PubMed Web of Science ®Google Scholar
• Zhang W, Li C, Shen C, et al. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment. Drug Deliv. 2016;23(7):2575–2580. doi:10.3109/10717544.2015.1035466
   PubMed Web of Science ®Google Scholar
• Chauhan G, Chopra V, Tyagi A, Rath G, Sharma RK, Goyal AK. “Gold nanoparticles composite-folic acid conjugated graphene oxide nanohybrids” for targeted chemo-thermal cancer ablation: in vitro screening and in vivo studies. Eur J Pharm Sci. 2017;96:351–361. doi:10.1016/j.ejps.2016.10.011
   PubMed Web of Science ®Google Scholar
• Mir Y, Elrington SA, Hasan T. A new nanoconstruct for epidermal growth factor receptor-targeted photo-immunotherapy of ovarian cancer. Nanomedicine. 2013;9(7):1114–1122. doi:10.1016/j.nano.2013.02.005
   PubMed Web of Science ®Google Scholar
• Min H, Wang J, Qi Y, et al. Biomimetic Metal-Organic Framework Nanoparticles for Cooperative Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacy. Adv Mater. 2019;31(15):e1808200. doi:10.1002/adma.201808200
   PubMed Web of Science ®Google Scholar
• Yue W, Chen L, Yu L, et al. Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice. Nat Commun. 2019;10(1):2025. doi:10.1038/s41467-019-09760-3
   PubMed Web of Science ®Google Scholar
• Xiao H, Song H, Yang Q, et al. A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance. Biomaterials. 2012;33(27):6507–6519. doi:10.1016/j.biomaterials.2012.05.049
   PubMed Web of Science ®Google Scholar
• Wang Y, Xie Y, Li J, et al. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. ACS Nano. 2017;11(2):2227–2238. doi:10.1021/acsnano.6b08731
   PubMed Web of Science ®Google Scholar
• Lu X, Wang QQ, Xu FJ, Tang GP, Yang WT. A cationic prodrug/therapeutic gene nanocomplex for the synergistic treatment of tumors. Biomaterials. 2011;32(21):4849–4856. doi:10.1016/j.biomaterials.2011.03.022
   PubMed Web of Science ®Google Scholar
• Li Y, Liu R, Yang J, Ma G, Zhang Z, Zhang X. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy. Biomaterials. 2014;35(36):9731–9745. doi:10.1016/j.biomaterials.2014.08.022
   PubMed Web of Science ®Google Scholar
• Galstyan A, Markman JL, Shatalova ES, et al. Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy. Nat Commun. 2019;10(1):3850. doi:10.1038/s41467-019-11719-3
   PubMedGoogle Scholar
• Park J, Wrzesinski SH, Stern E, et al. Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy. Nat Mater. 2012;11(10):895–905. doi:10.1038/nmat3355
   PubMed Web of Science ®Google Scholar
• Cheng K, Ding Y, Zhao Y, et al. Sequentially Responsive Therapeutic Peptide Assembling Nanoparticles for Dual-Targeted Cancer Immunotherapy. Nano Lett. 2018;18(5):3250–3258. doi:10.1021/acs.nanolett.8b01071
   PubMed Web of Science ®Google Scholar
• Teo PY, Cheng W, Hedrick JL, Yang YY. Co-delivery of drugs and plasmid DNA for cancer therapy. Adv Drug Deliv Rev. 2016;98:41–63. doi:10.1016/j.addr.2015.10.014
   PubMed Web of Science ®Google Scholar
• He C, Tang Z, Tian H, Chen X. Co-delivery of chemotherapeutics and proteins for synergistic therapy. Adv Drug Deliv Rev. 2016;98:64–76. doi:10.1016/j.addr.2015.10.021
   PubMed Web of Science ®Google Scholar
• Shapira A, Livney YD, Broxterman HJ, Assaraf YG. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Drug Resist Updat. 2011;14(3):150–163. doi:10.1016/j.drup.2011.01.003
   PubMed Web of Science ®Google Scholar
• Abeylath SC, Ganta S, Iyer AK, Amiji M. Combinatorial-designed multifunctional polymeric nanosystems for tumor-targeted therapeutic delivery. Acc Chem Res. 2011;44(10):1009–1017. doi:10.1021/ar2000106
   PubMed Web of Science ®Google Scholar
• Parekh G, Shi Y, Zheng J, Zhang X, Leporatti S. Nano-carriers for targeted delivery and biomedical imaging enhancement. Ther Deliv. 2018;9(6):451–468. doi:10.4155/tde-2018-0013
   PubMedGoogle Scholar
• Palanikumar L, Jeena MT, Kim K, et al. Spatiotemporally and Sequentially-Controlled Drug Release from Polymer Gatekeeper-Hollow Silica Nanoparticles. Sci Rep. 2017;7:46540. doi:10.1038/srep46540
   PubMed Web of Science ®Google Scholar
• Moss DM, Siccardi M. Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modeling. Br J Pharmacol. 2014;171(17):3963–3979. doi:10.1111/bph.12604
   PubMed Web of Science ®Google Scholar
• Rawal S, Patel MM. Threatening cancer with nanoparticle aided combination oncotherapy. J Control Release. 2019;301:76–109. doi:10.1016/j.jconrel.2019.03.015
   PubMed Web of Science ®Google Scholar
• Greco F, Vicent MJ. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev. 2009;61(13):1203–1213. doi:10.1016/j.addr.2009.05.006
   PubMed Web of Science ®Google Scholar
• Feng T, Tian H, Xu C, et al. Synergistic co- delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment. Eur J Pharm Biopharm. 2014;88(3):1086–1093. doi:10.1016/j.ejpb.2014.09.012
   PubMed Web of Science ®Google Scholar
• Al-Lazikani B, Banerji U, Workman P. Combinatorial drug therapy for cancer in the post-genomic era. Nat Biotechnol. 2012;30(7):679–692. doi:10.1038/nbt.2284
   PubMed Web of Science ®Google Scholar
• Xu JL, Jin B, Ren ZH, et al. Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: a Meta-Analysis. PLoS One. 2015;10(7):e0131278. doi:10.1371/journal.pone.0131278
   PubMed Web of Science ®Google Scholar
• Zhang X, Yang Y, Liang X, et al. Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer. Theranostics. 2014;4(11):1085–1095. doi:10.7150/thno.9933
   PubMed Web of Science ®Google Scholar
• Hu C, Gu F, Gong C, Xia Q, Gao Y, Gao S. Co-delivery of the autophagy inhibitor si-Beclin1 and the doxorubicin nano-delivery system for advanced prostate cancer treatment. J Biomater Appl. 2022;36(7):1317–1331. doi:10.1177/08853282211060252
   PubMed Web of Science ®Google Scholar
• Jia HZ, Zhang W, Zhu JY, et al. Hyperbranched-hyperbranched polymeric nanoassembly to mediate controllable co-delivery of siRNA and drug for synergistic tumor therapy. J Control Release. 2015;216:17.
   Web of Science ®Google Scholar
• Chen L, Qian M, Zhang L, et al. Co-delivery of doxorubicin and shRNA of Beclin1 by folate receptor targeted pullulan-based multifunctional nanomicelles for combinational cancer therapy. RSC Adv. 2018;8(32):17722.
   Web of Science ®Google Scholar
• Gao M, Xu Y, Qiu L. Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co -delivery via liposomes. Int J Nanomed. 2015;10:6615–6632. doi:10.2147/IJN.S91463
   PubMed Web of Science ®Google Scholar
• Schlinkert P, Casals E, Boyles M, et al. The oxidative potential of differently charged silver and gold nanoparticles on three human lung epithelial cell types. J Nanobiotechnology. 2015;13:1. doi:10.1186/s12951-014-0062-4
   PubMed Web of Science ®Google Scholar
• Xu J, Zhu X, Qiu L. Polyphosphazene vesicles for co-delivery of doxorubicin and chloroquine with enhanced anticancer efficacy by drug resistance reversal. Int J Pharm. 2016;498(1–2):70–81. doi:10.1016/j.ijpharm.2015.12.003
   PubMedGoogle Scholar
• Lin YX, Wang Y, An HW, et al. Peptide-Based Autophagic Gene and Cisplatin Co-delivery Systems Enable Improved Chemotherapy Resistance. Nano Lett. 2019;19(5):2968–2978. doi:10.1021/acs.nanolett.9b00083
   PubMed Web of Science ®Google Scholar
• Zhao X, Dong Y, Zhang J, et al. Reversing immune evasion using a DNA nano-orchestrator for pancreatic cancer immunotherapy. Acta Biomater. 2023;166(512):523. doi:10.1016/j.actbio.2023.05.001
   Google Scholar
• Zuo L, Nie W, Yu S, et al. Biomimetic Nanovesicle with Mitochondria-Synthesized Sonosensitizer and Mitophagy Inhibition for Cancer Sono-Immunotherapy. Nano Lett. 2023;23(7):3005–3013. doi:10.1021/acs.nanolett.3c00383
   PubMed Web of Science ®Google Scholar
• Yang X, Zhao M, Wu Z, et al. Nano-ultrasonic Contrast Agent for Chemoimmunotherapy of Breast Cancer by Immune Metabolism Reprogramming and Tumor Autophagy. ACS Nano. 2022;16(2):3417–3431. doi:10.1021/acsnano.2c00462
   PubMed Web of Science ®Google Scholar
• Zhu H, Gao X, Wang B, et al. A biodegradable hollow nanoagent enables a boosted chemodynamic therapy by simultaneous autophagy inhibition and macrophage reeducation. Int J Pharm. 2023;643:123248. doi:10.1016/j.ijpharm.2023.123248
   PubMedGoogle Scholar
• Nirosha Yalamandala B, Chen PH, Moorthy T, Huynh TMH, Chiang WH, Hu SH. Programmed Catalytic Therapy- Mediated ROS Generation and T-Cell Infiltration in Lung Metastasis by a Dual Metal-Organic Framework (MOF) Nanoagent. Pharmaceutics. 2022;14(3):527. doi:10.3390/pharmaceutics14030527
   PubMed Web of Science ®Google Scholar
• Chen M, Yang D, Sun Y, et al. In Situ Self-Assembly Nanomicelle Microneedles for Enhanced Photoimmunotherapy via Autophagy Regulation Strategy. ACS Nano. 2021;15(2):3387–3401. doi:10.1021/acsnano.0c10396
   PubMed Web of Science ®Google Scholar
• Luo Y, Li Y, Huang Z, et al. A Nanounit Strategy Disrupts Energy Metabolism and Alleviates Immunosuppression for Cancer Therapy. Nano Lett. 2022;22(15):6418–6427. doi:10.1021/acs.nanolett.2c02475
   PubMed Web of Science ®Google Scholar
• Ruan S, Xie R, Qin L, et al. Aggregable Nanoparticles-Enabled Chemotherapy and Autophagy Inhibition Combined with Anti-PD-L1 Antibody for Improved Glioma Treatment. Nano Lett. 2019;19(11):8332. doi:10.1021/acs.nanolett.9b03968
   Web of Science ®Google Scholar
• Li Y, Cho MH, Lee SS, Lee DE, Cheong H, Choi Y. Hydroxychloroquine-loaded hollow mesoporous silica nanoparticles for enhanced autophagy inhibition and radiation therapy. J Control Release. 2020;325:100–110. doi:10.1016/j.jconrel.2020.06.025
   PubMed Web of Science ®Google Scholar
• Ma Z, Lin K, Tang M, et al. A pH-Driven Small-Molecule Nanotransformer Hijacks Lysosomes and Overcomes Autophagy-Induced Resistance in Cancer. Angew Chem Int Ed Engl. 2022;61(35):e202204567. doi:10.1002/anie.202204567
   PubMed Web of Science ®Google Scholar
• Zhang X, Gao H, Wei D, et al. ROS Responsive Nanoparticles Encapsulated with Natural Medicine Remodel Autophagy Homeostasis in Breast Cancer. ACS Appl Mater Interfaces. 2023;15(25):29827–29840. doi:10.1021/acsami.3c03068
   PubMed Web of Science ®Google Scholar
• Li N, Gao Y, Li B, et al. Remote Manipulation of ROS-Sensitive Calcium Channel Using Near-Infrared-Responsive Conjugated Oligomer Nanoparticles for Enhanced Tumor Therapy In Vivo. Nano Lett. 2022;22(13):5427–5433. doi:10.1021/acs.nanolett.2c01472
   PubMedGoogle Scholar
• Wang L, Wang Y, Zhao W, et al. Library Screening to Identify Highly-Effective Autophagy Inhibitors for Improving Photothermal Cancer Therapy. Nano Lett. 2021;21(22):9476–9484. doi:10.1021/acs.nanolett.1c02825
   PubMed Web of Science ®Google Scholar
• Yang Y, Huang J, Liu M, et al. Emerging Sonodynamic Therapy-Based Nanomedicines for Cancer Immunotherapy. Adv Sci (Weinh). 2023;10(2):e2204365. doi:10.1002/advs.202204365
   PubMedGoogle Scholar
• Zhou L, Huo M, Qian MA. ROS-Responsive Nanomedicine: towards Targeting the Breast Tumor Microenvironment. Curr Med Chem. 2021;28(28):5674–5698. doi:10.2174/0929867328666201209100659
   PubMed Web of Science ®Google Scholar
• Zhou L, Huo M, Qian X, et al. Autophagy blockade synergistically enhances nanosonosensitizer-enabled sonodynamic cancer nanotherapeutics. J Nanobiotechnology. 2021;19(1):112. doi:10.1186/s12951-021-00855-y
   PubMed Web of Science ®Google Scholar
• Yu S, Chen Z, Zeng X, Chen X, Gu Z. Advances in nanomedicine for cancer starvation therapy. Theranostics. 2019;9(26):8026–8047. doi:10.7150/thno.38261
   PubMed Web of Science ®Google Scholar
• Yang B, Ding L, Chen Y, Shi J. Augmenting Tumor-Starvation Therapy by Cancer Cell Autophagy Inhibition. Adv Sci (Weinh). 2020;7(6):1902847. doi:10.1002/advs.201902847
   PubMedGoogle Scholar
• Liu X, Gao P, Shi M, et al. An autophagy-inhibitory MOF nanoreactor for tumor-targeted synergistic therapy. Biomater Sci. 2022;10(12):3088–3091. doi:10.1039/D2BM00579D
   PubMed Web of Science ®Google Scholar
• Deng Y, Jia F, Jiang P, et al. Biomimetic nanoparticle synchronizing pyroptosis induction and mitophagy inhibition for anti-tumor therapy. Biomaterials. 2023;301:122293. doi:10.1016/j.biomaterials.2023.122293
   PubMed Web of Science ®Google Scholar
• Wang T, Xiao G, Lu Q, et al. Synergistic Lysosomal Impairment and ER Stress Activation for Boosted Autophagy Dysfunction Based on Te Double-Headed Nano-Bullets. Small. 2022;18(27):e2201585. doi:10.1002/smll.202201585
   PubMed Web of Science ®Google Scholar
• Wang C, Li Z, Xu P, Xu L, Han S, Sun Y. Combination of polythyleneimine regulating autophagy prodrug and Mdr1 siRNA for tumor multidrug resistance. J Nanobiotechnology. 2022;20(1):476. doi:10.1186/s12951-022-01689-y
   PubMed Web of Science ®Google Scholar
• Wang X, Li Y, Jia F, Cui X, Pan Z, Wu Y. Boosting nutrient starvation -dominated cancer therapy through curcumin-augmented mitochondrial Ca2+ overload and obatoclax-mediated autophagy inhibition as supported by a novel nano-regulator GO-Alg@CaP/CO. J Nanobiotechnology. 2022;20(1):225. doi:10.1186/s12951-022-01439-0
   PubMed Web of Science ®Google Scholar
• Zhang H, Meng L, Yin L, et al. ClC-3 silencing mediates lysosomal acidification arrest and autophagy inhibition to sensitize chemo-photothermal therapy. Int J Pharm. 2022;628:122297. doi:10.1016/j.ijpharm.2022.122297
   PubMedGoogle Scholar
• Gao C, Kwong CHT, Wang Q, et al. Conjugation of Macrophage-Mimetic Microalgae and Liposome for Antitumor Sonodynamic Immunotherapy via Hypoxia Alleviation and Autophagy Inhibition. ACS Nano. 2023;17(4):4034–4049. doi:10.1021/acsnano.3c00041
   PubMed Web of Science ®Google Scholar
• Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005;5(9):726–734. doi:10.1038/nrc1692
   PubMed Web of Science ®Google Scholar
• Mele L, Del Vecchio V, Liccardo D, et al. The role of autophagy in resistance to targeted therapies. Cancer Treat Rev. 2020;88:102043. doi:10.1016/j.ctrv.2020.102043
   PubMed Web of Science ®Google Scholar
• Moscat J, Diaz-Meco MT. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell. 2009;137(6):1001–1004. doi:10.1016/j.cell.2009.05.023
   PubMed Web of Science ®Google Scholar
• Zhang X, Dong Y, Zeng X, et al. The effect of autophagy inhibitors on drug delivery using biodegradable polymer nanoparticles in cancer treatment. Biomaterials. 2014;35(6):1932–1943. doi:10.1016/j.biomaterials.2013.10.034
   PubMed Web of Science ®Google Scholar
• Yan J, Shan C, Zhang Z, et al. Autophagy-induced intracellular signaling fractional nano-drug system for synergistic anti-tumor therapy. J Colloid Interface Sci. 2023;645:986–996. doi:10.1016/j.jcis.2023.05.031
   PubMed Web of Science ®Google Scholar
• Mohammed SA, Ju Y. Multifunctional liposomal nanostructure-mediated siRNA/bortezomib co-delivery for SHARP1 knockdown in MLL-AF6 acute myeloid leukemia. Biomater Adv. 2022;134:112663. doi:10.1016/j.msec.2022.112663
   PubMedGoogle Scholar
• An J, Zhang K, Wang B, et al. Nanoenabled Disruption of Multiple Barriers in Antigen Cross-Presentation of Dendritic Cells via Calcium Interference for Enhanced Chemo-Immunotherapy. ACS Nano. 2020;14(6):7639–7650. doi:10.1021/acsnano.0c03881
   PubMed Web of Science ®Google Scholar
• Yu Z, Guo J, Hu M, Gao Y, Huang L. Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma. ACS Nano. 2020;14(4):4816–4828. doi:10.1021/acsnano.0c00708
   PubMed Web of Science ®Google Scholar
• Li TF, Xu YH, Li K, et al. Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy. Acta Biomater. 2019;86:381–394. doi:10.1016/j.actbio.2019.01.020
   PubMed Web of Science ®Google Scholar
• Wang Y, Lin YX, Wang J, et al. In Situ Manipulation of Dendritic Cells by an Autophagy-Regulative Nanoactivator Enables Effective Cancer Immunotherapy. ACS Nano. 2019;13(7):7568–7577. doi:10.1021/acsnano.9b00143
   PubMed Web of Science ®Google Scholar
• Yue H, Wei W, Gu Z, et al. Exploration of graphene oxide as an intelligent platform for cancer vaccines. Nanoscale. 2015;7(47):19957. doi:10.1039/C5NR04986E
   Web of Science ®Google Scholar
• Deng Y, Song P, Chen X, et al. 3-Bromopyruvate-Conjugated Nanoplatform-Induced Pro-Death Autophagy for Enhanced Photodynamic Therapy against Hypoxic Tumor. ACS Nano. 2020;14(8):9711–9727. doi:10.1021/acsnano.0c01350
   PubMed Web of Science ®Google Scholar
• Sun M, Wang C, Lv M, Fan Z, Du J. Mitochondrial-targeting nanoprodrugs to mutually reinforce metabolic inhibition and autophagy for combating resistant cancer. Biomaterials. 2021;278:121168. doi:10.1016/j.biomaterials.2021.121168
   PubMed Web of Science ®Google Scholar
• Liu R, Li Q, Qin S, et al. Sertaconazole- repurposed nanoplatform enhances lung cancer therapy via CD44-targeted drug delivery. J Exp Clin Cancer Res. 2023;42(1):188. doi:10.1186/s13046-023-02766-2
   PubMed Web of Science ®Google Scholar
• Kavya KV, Vargheese S, Shukla S, et al. A cationic amino acid polymer nanocarrier synthesized in supercritical CO2 for co-delivery of drug and gene to cervical cancer cells. Colloids Surf B Biointerfaces. 2022;216:112584. doi:10.1016/j.colsurfb.2022.112584
   PubMed Web of Science ®Google Scholar
• Hanafy NAN, Sheashaa RF, Moussa EA, Mahfouz ME. Potential of curcumin and niacin-loaded targeted chitosan coated liposomes to activate autophagy in hepatocellular carcinoma cells: an in vitro evaluation in HePG2 cell line. Int J Biol Macromol. 2023;245:125572. doi:10.1016/j.ijbiomac.2023.125572
   PubMed Web of Science ®Google Scholar
• Chen J, Xue F, Du W, et al. An Endogenous H2S-Activated Nanoplatform for Triple Synergistic Therapy of Colorectal Cancer. Nano Lett. 2022;22(15):6156–6165. doi:10.1021/acs.nanolett.2c01346
   PubMed Web of Science ®Google Scholar
• Zhang R, Xu S, Yuan M, et al. An ultrasmall PVP-Fe-Cu -Ni-S nano-agent for synergistic cancer therapy through triggering ferroptosis and autophagy. Nanoscale. 2023;15(30):12598–12611. doi:10.1039/D3NR02708B
   PubMed Web of Science ®Google Scholar
• Li F, Chen T, Wang F, et al. Enhanced Cancer Starvation Therapy Enabled by an Autophagy Inhibitors-Encapsulated Biomimetic ZIF-8 Nanodrug: disrupting and Harnessing Dual Pro-Survival Autophagic Responses. ACS Appl Mater Interfaces. 2022;14(19):21860–21871. doi:10.1021/acsami.2c00552
   PubMedGoogle Scholar
• Yin W, Pham CV, Wang T, et al. Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin. Biomolecules. 2022;12(11):1623. doi:10.3390/biom12111623
   PubMed Web of Science ®Google Scholar
• Ghosh C, Nandi A, Basu S. Supramolecular self-assembly of triazine-based small molecules: targeting the endoplasmic reticulum in cancer cells. Nanoscale. 2019;11(7):3326–3335. doi:10.1039/C8NR08682F
   PubMed Web of Science ®Google Scholar
• Wu J, Huang X, Xiao Z, et al. Nano-Pt mitochondria induced-dependent apoptosis and cytoprotective autophagy in human NSCLC cells. Colloids Surf B Biointerfaces. 2023;227:113344. doi:10.1016/j.colsurfb.2023.113344
   PubMed Web of Science ®Google Scholar
• Adiseshaiah PP, Clogston JD, McLeland CB, et al. Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models. Cancer Lett. 2013;337(2):254–265. doi:10.1016/j.canlet.2013.04.034
   PubMed Web of Science ®Google Scholar
• Shaw JJP, Boyer TL, Venner E, et al. Inhibition of Lysosomal Function Mitigates Protective Mitophagy and Augments Ceramide Nanoliposome-Induced Cell Death in Head and Neck Squamous Cell Carcinoma. Mol Cancer Ther. 2020;19(12):2621–2633. doi:10.1158/1535-7163.MCT-20-0182
   PubMed Web of Science ®Google Scholar
• Li N, Han S, Ma B, et al. Chemosensitivity enhanced by autophagy inhibition based on a polycationic nano-drug carrier. Nanoscale Adv. 2021;3(6):1656–1673. doi:10.1039/D0NA00990C
   PubMed Web of Science ®Google Scholar
• Xie Y, Jiang J, Tang Q, et al. Iron Oxide Nanoparticles as Autophagy Intervention Agents Suppress Hepatoma Growth by Enhancing Tumoricidal Autophagy. Adv Sci (Weinh). 2020;7(16):1903323. doi:10.1002/advs.201903323
   PubMedGoogle Scholar
• Zhang P, Shi Y, Xu Y, et al. A Nano-Autophagy Inhibitor Triggering Reciprocal Feedback Control of Cholesterol Depletion for Solid Tumor Therapy. Adv Healthc Mater;2023. e2302020. doi:10.1002/adhm.202302020
   PubMed Web of Science ®Google Scholar
• Lu HY, Chang YJ, Fan NC, et al. Synergism through combination of chemotherapy and oxidative stress-induced autophagy in A549 Lung cancer cells using redox-responsive nanohybrids: a new strategy for cancer therapy. Biomaterials. 2015;42:30–41. doi:10.1016/j.biomaterials.2014.11.029
   PubMed Web of Science ®Google Scholar
• Wang XS, Zeng JY, Li MJ, Li QR, Gao F, Zhang XZ. Highly Stable Iron Carbonyl Complex Delivery Nanosystem for Improving Cancer Therapy. ACS Nano. 2020;14(8):9848–9860. doi:10.1021/acsnano.0c02516
   PubMed Web of Science ®Google Scholar
• Lv C, Kang W, Liu S, et al. Growth of ZIF-8 Nanoparticles In Situ on Graphene Oxide Nanosheets: a Multifunctional Nanoplatform for Combined Ion-Interference and Photothermal Therapy. ACS Nano. 2022;16(7):11428–11443. doi:10.1021/acsnano.2c05532
   PubMed Web of Science ®Google Scholar
• Zhou Y, Han Y, Li G, Yang S, Xiong F, Chu F. Preparation of Targeted Lignin⁻Based Hollow Nanoparticles for the Delivery of Doxorubicin. Nanomaterials (Basel). 2019;9(2):188. doi:10.3390/nano9020188
   PubMedGoogle Scholar
• Andhari SS, Wavhale RD, Dhobale KD, et al. Self-Propelling Targeted Magneto -Nanobots for Deep Tumor Penetration and pH-Responsive Intracellular Drug Delivery. Sci Rep. 2020;10(1):4703. doi:10.1038/s41598-020-61586-y
   PubMed Web of Science ®Google Scholar
• Gavini J, Dommann N, Jakob MO, et al. Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma. Cell Death Dis. 2019;10(10):749. doi:10.1038/s41419-019-1989-z
   PubMed Web of Science ®Google Scholar
• Xu Y, Zheng H, Kang JS, et al. 5-Nitro-2-(3-phenylpropylamino) benzoic acid induced drug resistance to cisplatin in human erythroleukemia cell lines. Anat Rec (Hoboken). 2011;294(6):945–952. doi:10.1002/ar.21392
   PubMedGoogle Scholar
• Seebacher NA, Richardson DR, Jansson PJ. A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC. Cell Death Dis. 2016;7(12):e2510. doi:10.1038/cddis.2016.381
   PubMedGoogle Scholar
• Zhu X, Ji X, Kong N, et al. Intracellular Mechanistic Understanding of 2D MoS2 Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer Therapy. ACS Nano. 2018;12(3):2922–2938. doi:10.1021/acsnano.8b00516
   PubMed Web of Science ®Google Scholar
• Yin Y, Wang J, Yang M, et al. Penetration of the blood-brain barrier and the anti-tumour effect of a novel PLGA-lysoGM1/DOX micelle drug delivery system. Nanoscale. 2020;12(5):2946–2960. doi:10.1039/C9NR08741A
   PubMed Web of Science ®Google Scholar
• Ding L, Zhu X, Wang Y, et al. Intracellular Fate of Nanoparticles with Polydopamine Surface Engineering and a Novel Strategy for Exocytosis-Inhibiting, Lysosome Impairment-Based Cancer Therapy. Nano Lett. 2017;17(11):6790–6801. doi:10.1021/acs.nanolett.7b03021
   PubMed Web of Science ®Google Scholar
• Lin YW, Lin TT, Chen CH, et al. Enhancing Efficacy of Albumin-Bound Paclitaxel for Human Lung and Colorectal Cancers through Autophagy Receptor Sequestosome 1 (SQSTM1)/p62-Mediated Nanodrug Delivery and Cancer therapy. ACS Nano. 2023. doi:10.1021/acsnano.3c04739
   Web of Science ®Google Scholar
• Kong C, Li Y, Liu Z, et al. Targeting the Oncogene KRAS Mutant Pancreatic Cancer by Synergistic Blocking of Lysosomal Acidification and Rapid Drug Release. ACS Nano. 2019;13(4):4049–4063. doi:10.1021/acsnano.8b08246
   PubMed Web of Science ®Google Scholar
• Li X, Wang ZG, Zhu H, et al. Inducing Autophagy and Blocking Autophagic Flux via a Virus-Mimicking Nanodrug for Cancer Therapy. Nano Lett. 2022;22(22):9163–9173. doi:10.1021/acs.nanolett.2c04091
   PubMedGoogle Scholar
• Jiang L, Liang X, Liu G, et al. The mechanism of lauric acid-modified protein nanocapsules escape from intercellular trafficking vesicles and its implication for drug delivery. Drug Deliv. 2018;25(1):985–994. doi:10.1080/10717544.2018.1461954
   PubMed Web of Science ®Google Scholar
• Zhang Q, Yang W, Man N, et al. Autophagy-mediated chemosensitization in cancer cells by fullerene C60 nanocrystal. Autophagy. 2009;5(8):1107–1117. doi:10.4161/auto.5.8.9842
   PubMed Web of Science ®Google Scholar
• Xiong Q, Liu A, Ren Q, et al. Cuprous oxide nanoparticles trigger reactive oxygen species-induced apoptosis through activation of erk-dependent autophagy in bladder cancer. Cell Death Dis. 2020;11(5):366. doi:10.1038/s41419-020-2554-5
   PubMed Web of Science ®Google Scholar
• Liu M, Liu Z, Qin G, Ren J, Qu X. Bioorthogonally Activatable Autophagy-Tethering Compounds for Aptamer-Guided Mitochondrial Degradation. Nano Lett. 2023;23(11):4965–4973. doi:10.1021/acs.nanolett.3c00798
   PubMed Web of Science ®Google Scholar
• Chen F, Zhang XH, Hu XD, Liu PD, Zhang HQ. The effects of combined selenium nanoparticles and radiation therapy on breast cancer cells in vitro. Artif Cells Nanomed Biotechnol. 2018;46(5):937–948. doi:10.1080/21691401.2017.1347941
   PubMed Web of Science ®Google Scholar
• Liu Z, Tan H, Zhang X, et al. Enhancement of radiotherapy efficacy by silver nanoparticles in hypoxic glioma cells. Artif Cells Nanomed Biotechnol. 2018;46(sup3):S922–S930. doi:10.1080/21691401.2018.1518912
   PubMed Web of Science ®Google Scholar
• Liu P, Jin H, Guo Z, et al. Silver nanoparticles outperform gold nanoparticles in radiosensitizing U251 cells in vitro and in an intracranial mouse model of glioma. Int J Nanomed. 2016;11:5003–5014. doi:10.2147/IJN.S115473
   PubMed Web of Science ®Google Scholar
• Ma S, Miao H, Luo Y, et al. FePt/GO Nanosheets Suppress Proliferation, Enhance Radiosensitization and Induce Autophagy of Human Non-Small Cell Lung Cancer Cells. Int J Biol Sci. 2019;15(5):999–1009. doi:10.7150/ijbs.29805
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu Z, Lou Z, et al. Radiosensitivity enhancement of Fe3O4@Ag nanoparticles on human glioblastoma cells. Artif Cells Nanomed Biotechnol. 2018;46(sup1):975–984. doi:10.1080/21691401.2018.1439843
   PubMed Web of Science ®Google Scholar
• Li F, Li Z, Jin X, et al. Ultra-small gadolinium oxide nanocrystal sensitization of non-small-cell lung cancer cells toward X-ray irradiation by promoting cytostatic autophagy. Int J Nanomed. 2019;14:2415–2431. doi:10.2147/IJN.S193676
   PubMed Web of Science ®Google Scholar
• Sadhukha T, Wiedmann TS, Panyam J. Enhancing therapeutic efficacy through designed aggregation of nanoparticles. Biomaterials. 2014;35(27):7860–7869.
   PubMed Web of Science ®Google Scholar
• Zhang L, Jia Y, Yang J, et al. Efficient Immunotherapy of Drug-Free Layered Double Hydroxide Nanoparticles via Neutralizing Excess Acid and Blocking Tumor Cell Autophagy. ACS Nano. 2022;16(8):12036–12048. doi:10.1021/acsnano.2c02183
   PubMed Web of Science ®Google Scholar
• Jia Y, Hu J, Zhu C, et al. Engineered NanoAlum from aluminum turns cold tumor hot for potentiating cancer metalloimmunotherapy. J Control Release. 2023;354:770–783. doi:10.1016/j.jconrel.2023.01.043
   PubMed Web of Science ®Google Scholar
• Xu J, Wang H, Hu Y, et al. Inhibition of CaMKIIα Activity Enhances Antitumor Effect of Fullerene C60 Nanocrystals by Suppression of Autophagic Degradation. Adv Sci (Weinh). 2019;6(8):1801233.
   PubMedGoogle Scholar
• Chen Y, Yang L, Feng C, Wen LP. Nano neodymium oxide induces massive vacuolization and autophagic cell death in non-small cell lung cancer NCI-H460 cells. Biochem Biophys Res Commun. 2005;337(1):52–60.
   PubMed Web of Science ®Google Scholar
• Hao BM, Liu YN, Zhang CY, et al. Autophagic blockage by bismuth sulfide nanoparticles inhibits migration and invasion of HepG2 cells. Nanotechnology. 2020;31(46):465102. doi:10.1088/1361-6528/abadc6
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang Y, Fu Y, et al. Reductive damage induced autophagy inhibition for tumor therapy. Nano Res. 2023;16(4):5226–5236. doi:10.1007/s12274-022-5139-z
   PubMed Web of Science ®Google Scholar
• Ray E, Vaghasiya K, Sharma A, et al. Autophagy-Inducing Inhalable Co-crystal Formulation of Niclosamide-Nicotinamide for Lung Cancer Therapy. AAPS Pharm Sci Tech. 2020;21(7):260.
   PubMed Web of Science ®Google Scholar
• Yang F, Wang X, Sun J, et al. Mesopore-encaged active MnOx in nano-silica selectively suppresses lung cancer cells by inducing autophagy. Biomater Sci. 2023;11(6):2056–2064. doi:10.1039/D2BM01826H
   PubMed Web of Science ®Google Scholar
• Liu Z, Du Z, Li K, Han Y, Ren G, Yang Z. TRPC6-Mediated Ca2+ Entry Essential for the Regulation of Nano-ZnO Induced Autophagy in SH-SY5Y Cells. Neurochem Res. 2020;45(7):1602–1613. doi:10.1007/s11064-020-03025-y
   PubMed Web of Science ®Google Scholar
• Yang R, Wu R, Mei J, Hu FR, Lei CJ. Zinc oxide nanoparticles promotes liver cancer cell apoptosis through inducing autophagy and promoting p53. Eur Rev Med Pharmacol Sci. 2021;25(3):1557–1563.
   PubMed Web of Science ®Google Scholar
• Du Z, Chai X, Li X, Ren G, Yang X, Yang Z. Nano-CuO causes cell damage through activation of dose-dependent autophagy and mitochondrial lncCyt b-AS/ND5-AS/ND6-AS in SH-SY5Y cells. Toxicol Mech Methods. 2022;32(1):37–48. doi:10.1080/15376516.2021.1964665
   PubMed Web of Science ®Google Scholar
• Wen J, Chen H, Ren Z, Zhang P, Chen J, Jiang S. Ultrasmall iron oxide nanoparticles induced ferroptosis via Beclin1/ATG5-dependent autophagy pathway. Nano Converg. 2021;8(1):10. doi:10.1186/s40580-021-00260-z
   PubMed Web of Science ®Google Scholar
• Zamanvaziri A, Meshkat M, Alazmani S, Khaleghi S, Hashemi M. Targeted PEGylated Chitosan Nano-complex for Delivery of Sodium Butyrate to Prostate Cancer: an In Vitro Study. Technol Cancer Res Treat. 2023;22:15330338231159223. doi:10.1177/15330338231159223
   Web of Science ®Google Scholar
• Menconi A, Marzo T, Massai L, et al. Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA-PEG nanoparticles. Biometals. 2021;34(4):867–879. doi:10.1007/s10534-021-00313-0
   PubMed Web of Science ®Google Scholar
• Luo H, Lu L, Yang F, et al. Nasopharyngeal cancer-specific therapy based on fusion peptide-functionalized lipid nanoparticles. ACS Nano. 2014;8(5):4334–4347. doi:10.1021/nn405989n
   PubMed Web of Science ®Google Scholar
• Kim I, Song YH, Singh N, et al. Anticancer activities of self-assembled molecular bowls containing a phenanthrene-based donor and Ru(II) acceptors. Int J Nanomed. 2015;10:143–153. doi:10.2147/IJN.S88287
   PubMed Web of Science ®Google Scholar
• Shi M, Cheng L, Zhang Z, Liu Z, Mao X. Ferroferric oxide nanoparticles induce prosurvival autophagy in human blood cells by modulating the Beclin 1/Bcl-2/VPS34 complex. Int J Nanomed. 2014;10(207):–. doi:10.2147/IJN.S72598
   Google Scholar
• Becker AL, Orlotti NI, Folini M, et al. Redox-active polymer microcapsules for the delivery of a survivin-specific siRNA in prostate cancer cells. ACS Nano. 2011;5(2):1335–1344. doi:10.1021/nn103044z
   PubMed Web of Science ®Google Scholar
• Aryal S, Hu CM, Zhang L. Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. Mol Pharm. 2011;8(4):1401–1407. doi:10.1021/mp200243k
   PubMedGoogle Scholar
• Huang P, Wang D, Su Y, et al. Combination of small Molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy. J Am Chem Soc. 2014;136(33):11748–11756. doi:10.1021/ja505212y
   PubMed Web of Science ®Google Scholar